SCHEMBL1665510

SCHEMBL1665510

CCOC(=O)c1ccc2cccccc1-2

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.61
SCN1A P35498 3/20 0.60
SCN2A Q99250 3/20 0.60
SCN3A Q9NY46 3/20 0.60
LMNA P02545 3/20 0.55
ALDH1A1 P00352 7/20 0.53
HSD17B10 Q99714 2/20 0.53
MAPT P10636 6/20 0.52
SMN1; SMN2 Q16637 5/20 0.52
RAB9A P51151 4/20 0.52
GAA P10253 3/20 0.52
HPGD P15428 3/20 0.52
ALOX15 P16050 2/20 0.52
MEN1 O00255 2/20 0.52
CYP1A2 P05177 2/20 0.52
CYP3A4 P08684 2/20 0.52
CYP2C9 P11712 2/20 0.52
CYP2C19 P33261 2/20 0.52
KMT2A Q03164 2/20 0.52
USP2 O75604 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27686802 0.95 TSHR (0.65) TSHRSCN1ASCN2ASCN3ALMNA
SCHEMBL396552 0.95 TSHR (0.69) TSHRSCN1ASCN2ASCN3ALMNA
Bicarbonate SCHEMBL27449726 0.93 TSHR (0.67) TSHRSCN1ASCN2ASCN3ALMNA
SCHEMBL29500171 0.88 TSHR (0.65) TSHRSCN1ASCN2ASCN3ALMNA
SCHEMBL3230316 0.88 TSHR (0.65) TSHRSCN1ASCN2ASCN3ALMNA
SCHEMBL27686775 0.87 TSHR (0.59) TSHRSCN1ASCN2ASCN3ALMNA
Bicarbonate SCHEMBL5706047 0.87 TSHR (0.62) TSHRSCN1ASCN2ASCN3ALMNA
SCHEMBL8606461 0.87 TSHR (0.62) TSHRSCN1ASCN2ASCN3ALMNA
SCHEMBL8873262 0.85 TSHR (0.61) TSHRSCN1ASCN2ASCN3ALMNA
SCHEMBL10476975 0.85 TSHR (0.61) TSHRSCN1ASCN2ASCN3ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113773494-A Resin composition, resin film and display device 许翔 2021-12-10 CN disclosed
EP-2486043-A1 [18 F]- LABELLED ANALOGUES OF FLUMAZENIL AS IN VIVO IMAGING AGENTS GE Healthcare UK Limited (GB) 2012-08-15 EP disclosed
WO-2011042550-A1 [18 F] - LABELLED ANALOGUES OF FLUMAZENIL AS IN VIVO IMAGING AGENTS GE HEALTHCARE LIMITED (GB) 2011-04-14 WO disclosed
EP-1761508-A1 STEREOSPECIFIC ANXIOLYTIC AND ANTICONVULSANT AGENTS WITH REDUCED MUSCLE-RELAXANT, SEDATIVE-HYPNOTIC AND ATAXIC EFFECTS WISYS TECHNOLOGY FOUNDATION, INC. (US) 2007-03-14 EP disclosed
WO-2006004945-A1 STEREOSPECIFIC ANXIOLYTIC AND ANTICONVULSANT AGENTS WITH REDUCED MUSCLE-RELAXANT, SEDATIVE-HYPNOTIC AND ATAXIC EFFECTS WISYS TECHNOLOGY FOUNDATION, INC. (US) 2006-01-12 WO disclosed
EP-1337535-A2 BENZODIAZEPINE DERIVATIVES AS GABA A RECEPTOR MODULATORS F. HOFFMANN-LA ROCHE AG (CH) 2003-08-27 EP disclosed
EP-1325006-A2 HETEROCYCLIC COMPOUNDS AS LIGANDS OF THE GABA A? RECEPTOR NEUROGEN CORPORATION (US) 2003-07-09 EP disclosed
WO-2002040487-A2 BENZODIAZEPINE DERIVATIVES AS GABA A RECEPTOR MODULATORS F. HOFFMANN-LA ROCHE AG (CH) 2002-05-23 WO disclosed
WO-2002012442-A2 HETEROCYCLIC COMPOUNDS AS LIGANDS OF THE GABAA RECEPTOR NEUROGEN CORPORATION (US) 2002-02-14 WO disclosed